TherapeuticsMD | TXMD - Equity Capital And Reserves


TherapeuticsMD reported $27.67M in Equity Capital and Reserves for its fiscal quarter ending in June of 2024.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 21.41B 861M Jun/2025
Grifols EUR 6.08B 34.72M Sep/2025
Novo Nordisk DKK 26.56B 111.98B Jun/2025
Pfizer USD 92.8B 4.11B Sep/2025
TherapeuticsMD USD 27.67M 990K Jun/2024